Genetically engineered immune cells show promise in reducing arterial plaque buildup, a significant factor in cardiovascular diseases, thereby potentially decreasing the risk of heart attacks and strokes in patients unresponsive to traditional treatments.
Current treatment methods for individuals at high risk typically involve statins, but these medications do not provide adequate protection for everyone. “If statins were perfect, we wouldn’t see such a persistent issue with cardiovascular disease, which remains the leading cause of death globally,” states an expert from a leading research institution.
